ArsenalBio – Talk Bio

Actionable Insights Powered by AI

ArsenalBio Secures $325M Funding to Advance Programmable CAR-T Therapies

8 months ago talkbio0Tagged ArsenalBio, Burning Mouth Syndrome, CAR-T, Cell Therapy, Regeneron, Solid Neoplasm

ArsenalBio, CAR-T therapies, biotech funding, programmable cell therapies, solid tumors, Regeneron, BMS

ArsenalBio Secures $325M in Series C Funding for Solid Tumor Cell Therapy Trials

8 months ago talkbio0Tagged ArsenalBio, Cell Therapy, Investments, Series C, solid tumor trials

ArsenalBio, cell therapy, solid tumor trials, Series C funding, biotech investment